AYTU BIOPHARMA, INC Due to Related Parties, Current
AYTU BIOPHARMA, INC (AYTU) had Due to Related Parties, Current of $38.45 thousand as of 2015-12-31, per its 10-Q filed 2016-02-11.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2016-02-11
- 2015-12-31: Due to Related Parties, Current $38.45K.
- 2015-06-30: Due to Related Parties, Current $0.00.
- 2015-02-28: Due to Related Parties, Current $36.49K.
- 2014-11-30: Due to Related Parties, Current $31.99K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2015-12-31 | $38.45K 10-Q · filed 2016-02-11 |
| 2015-06-30 | $0.00 10-Q · filed 2016-02-11 |
| 2015-02-28 | $36.49K 10-Q · filed 2015-04-15 |
| 2014-11-30 | $31.99K 10-Q · filed 2015-01-12 |
| 2014-08-31 | $30.98K 10-Q · filed 2015-04-15 |
| 2014-06-30 | $150.00K 10-Q · filed 2015-05-19 |
| 2014-05-31 | $28.53K 10-Q · filed 2014-07-10 |
| 2014-02-28 | $113.03K 10-Q · filed 2014-04-11 |
| 2013-11-30 | $104.95K 10-Q · filed 2014-01-10 |
| 2013-08-31 | $99.51K 10-K · filed 2014-11-26 |
| 2013-05-31 | $96.14K 10-Q · filed 2013-06-28 |
| 2013-02-28 | $83.33K 10-Q · filed 2013-04-15 |
| 2012-11-30 | $72.56K 10-Q · filed 2013-01-14 |
| 2012-08-31 | $68.05K 10-K · filed 2014-11-26 |
| 2012-05-31 | $55.43K 10-Q · filed 2012-06-26 |
| 2012-02-29 | $55.05K 10-Q · filed 2012-04-12 |
| 2011-11-30 | $55.05K 10-Q · filed 2011-12-23 |
| 2011-08-31 | $52.30K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |